Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Friedreich’s Ataxia Therapy News

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Friedreich’s Ataxia Therapy News - Very interesting

in response to

Re: Friedreich’s Ataxia Therapy News - Very interesting

Toinv

posted on May 26, 2017 02:27PM

Toniv,

See my post from a day or two ago. In the patent, all Pfizer has done is test RVX-208 and a battery of other BET inhibitors in human cells. No Friedreich’s Ataxia patients have been treated with any BET inhibitor in any clinical trial yet. To study a Friedreich’s Ataxia indication, I think the interested party would need to file a new IND as well as start in Phase I trials. To the best of my knowledge neither has happened yet.